M. Hosseinnia et al., CREATINE-KINASE ISOFORMS AS CIRCULATING MARKERS OF DETERIORATION IN IDIOPATHIC DILATED CARDIOMYOPATHY, Clinical cardiology, 20(1), 1997, pp. 55-60
Background: A proportion of patients with dilated cardiomyopathy (DCM)
may have ongoing myocardial damage secondary to viral or immune media
ted myocardial inflammation. Hypothesis: The prognostic determinants i
dentify patients with decreased survival but do not provide a measure
of myocardial damage. To obtain an objective assessment of myocardial
damage in DCM, we measured plasma levels of creatine kinase (CK), its
isoenzymes (CK-MM and CK-MB), and separated the isoforms of CK-MM and
CK-MB. Methods: The cohort consisted of 77 consecutive patients (61 me
n, 16 women) with DCM (World Health Organization criteria), aged 49 +/
- 14 years (range 19-60). Patients had been symptomatic for 29 +/- 38
months (range 0.5-200 months) with 48 in New York Heart Association cl
ass I/II and 29 in class III/IV at the time of diagnosis. During media
n follow-up of 27 months from diagnosis (range 0.6-165), 50 patients r
emained clinically stable and 27 had deteriorated. Results: A signific
antly higher proportion of patients with DCM had abnormal MB2/MB1 rati
o compared with normal volunteers (11, 14% vs. 1, 1%, p = 0.003). Pati
ents who deteriorated had higher MB2/MB1 ratio, (1.22 +/- 0.62 vs. 0.8
5 +/- 0.56; p = 0.01), and more frequently had abnormal MB2/MB1 ratio
(8, 30% vs. 3, 6%; p = 0.004) and CK and CK-MM activities (5, 19% vs.
2, 4%; p = 0.03) than those who remained stable. Patients with DCM wit
h high CK-MB activity had 3.13-fold increased odds of sudden death or
need for cardiac transplantation (95% confidence interval 1.53-6.40, p
= 0.008). Thus, CK measurements, in particular CK-MB isoforms, are ma
rkers of myocardial damage in a subset of patients with DCM and could
be useful in investigating the possibility of persistent myocardial da
mage in these patients.